IBJNews

Lilly to close drug discovery center in Singapore

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. will close its drug discovery center in Singapore, three years into a five-year, $150 million plan to expand it.

About 130 employees will be affected by the closure, which will take effect as of the end of December, a Singapore-based external spokeswoman who declined to be identified said in an e-mail Monday. Projects developed in the city-state will be transferred to the company’s headquarters in Indianapolis, she said. Dow Jones Newswires reported the news earlier.

Lilly is on track to cut costs by about $1 billion by 2011, Chief Executive Officer John Lechleiter said in September. The company said last year it was reorganizing its research operations to address an “increasingly complex, slow and expensive” drug development process.

The closure “is part of our ongoing business reviews to ensure we are structured to most efficiently bring innovative new medicines to patients,” the spokeswoman said.

Lilly said in 2007 it planned to spend $150 million over five years to expand the center, with a focus on translating basic research into treatments for cancer and type 2 diabetes. The company said it planned to identify two potential drug candidates at the center within five years. The center’s employees will be able to apply for “limited jobs” at Lilly’s headquarters or to take a severance package, the company said.

The announcement comes nine days after Singapore’s government said it wanted to strengthen ties between government-funded scientists and institutes as it seeks to hasten returns on its investment in research and development. Singapore has spent almost S$20 billion ($15 million) over the past decade to become a scientific research hub and plans to spend S$16.1 billion over the next five years, it said.

“We regret Lilly’s decision,” Beh Kian Teik, director of biomedical sciences at Singapore’s Economic Development Board, said in an e-mailed statement.

Novartis AG, GlaxoSmithKline Plc and Roche Holding AG have also set up research labs in the city state. Lilly will continue to operate a clinical trial unit at the National University of Singapore, it said.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. Kent's done a good job of putting together some good guests, intelligence and irreverence without the inane chatter of the other two shows. JMV is unlistenable, mostly because he doesn't do his homework and depends on non-sports stuff to keep HIM interested. Query and Shultz is a bit better, but lack of prep in their show certainly is evident. Sterling obviously workes harder than the other shows. We shall see if there is any way for a third signal with very little successful recent history to make it. I always say you have to give a show two years to grow into what it will become...

  2. Lafayette Square, Washington Square should be turned into office parks with office buildings, conversion, no access to the public at all. They should not be shopping malls and should be under tight security and used for professional offices instead of havens for crime. Their only useage is to do this or tear them down and replace them with high rise office parks with secured parking lots so that the crime in the areas is not allowed in. These are prime properties, but must be reused for other uses, professional office conversions with no loitering and no shopping makes sense, otherwise they have become hangouts long ago for gangs, groups of people who have no intent of spending money, and are only there for trouble and possibly crime, shoplifting, etc. I worked summers at SuperX Drugs in Lafayette Square in the 1970s and even then the shrinkage from shoplifting was 10-15 percent. No sense having shopping malls in these areas, they earn no revenue, attract crime, and are a blight on the city. All malls that are not of use should be repurposed or torn down by the city, condemned. One possibility would be to repourpose them as inside college campuses or as community centers, but then again, if the community is high crime, why bother.

  3. Straight No Chaser

  4. Seems the biggest use of TIF is for pet projects that improve Quality Of Life, allegedly, but they ignore other QOL issues that are of a more important and urgent nature. Keep it transparent and try not to get in ready, fire, Aim! mode. You do realize that business the Mayor said might be interested is probably going to want TIF too?

  5. Gary, I'm in complete agreement. The private entity should be required to pay IPL, and, if City parking meters are involved, the parking meter company. I was just pointing out how the poorly-structured parking meter deal affected the car share deal.

ADVERTISEMENT